Articles about Johnson & Johnson
15 Sep 2021
35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab
Around 35 lakh doses of the COVID-19 vaccine developed by United States pharma giant Johnson & Johnson have reportedly reached the apex vaccine testing laboratory in Kasauli, Himachal Pradesh.
09 Sep 2021
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October
The one-dose COVID-19 vaccine developed by American pharma giant Johnson & Johnson and manufactured by the company's local partner, Hyderabad-based Biological E, is likely to be available in India by October, reported News18.
07 Aug 2021
J&J's one-dose COVID-19 vaccine gets the nod in India
India has approved Johnson & Johnson's single-dose coronavirus vaccine for emergency use, the Union Health Minister Mansukh Mandaviya announced today.
06 Aug 2021
J&J applies for EUA of COVID-19 vaccine in India
Global healthcare major Johnson & Johnson on Friday said that it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine in India.
02 Aug 2021
J&J withdraws vaccine approval request in India, CDSCO says
Johnson & Johnson has withdrawn its proposal seeking an accelerated approval of its COVID-19 vaccine, Janssen, in India, the country's drug regulator said.
13 Jul 2021
FDA adds warning of rare reaction risk to J&J vaccine
US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction but said it's not entirely clear the shot caused the problem.
02 Jul 2021
Johnson & Johnson says its vaccine works against Delta variant
Johnson & Johnson's one-shot coronavirus vaccine is effective against the highly-contagious Delta variant and provides durable protection against infection overall, the company said in a statement on Thursday.
11 Jun 2021
J&J COVID-19 vaccine's expiration date extended by six weeks
Johnson & Johnson said on Thursday that US regulators extended the expiration date on its COVID-19 vaccine doses by six weeks.
19 May 2021
J&J partners with India's Biological E to produce COVID-19 vaccine
American pharmaceutical giant Johnson & Johnson has partnered with the Indian firm Biological E. Limited for the production of its COVID-19 vaccine, a move that could boost the country's overall supplies amid a serious shortage.
12 May 2021
US looking to produce of J&J's COVID-19 vaccine in India
The United States is considering the production of Johnson & Johnson's COVID-19 vaccine in India along with ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, Charge d'Affaires of the US Embassy, said on Tuesday.
24 Apr 2021
US to resume J&J COVID-19 vaccinations despite rare clot risk
US health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's single-dose shot, after advisers decided its benefits outweigh a rare risk of a blood clot.
22 Apr 2021
US faces pressure to decide J&J COVID-19 vaccine's fate
US agencies are under pressure to take a call on the resumption of the use of Johnson & Johnson's COVID-19 vaccine.
20 Apr 2021
J&J seeks permission to conduct COVID-19 vaccine trial in India
US healthcare giant Johnson & Johnson said on Tuesday that it has sought approval from India's drug regulator to conduct a bridging clinical study of its single-dose COVID-19 vaccine in the country.
15 Apr 2021
South Africa suspends Johnson & Johnson COVID-19 vaccine
South Africa has joined the US in suspending its roll-out of the Johnson & Johnson COVID-19 vaccine, following reports that six women who received the immunization doses had developed unusual blood clots with low platelet count.
13 Apr 2021
United States recommends 'pause' on J&J vaccine after clotting concerns
The United States government recommended a "pause" in the administration of the single-dose Johnson & Johnson (J&J) vaccine amid concerns of a "rare and severe type of blood clot."
09 Apr 2021
J&J set to begin India trial of its single-shot vaccine
US pharmaceutical giant Johnson & Johnson is in talks with the Indian government to soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the company said on Friday.
01 Apr 2021
15 million J&J vaccine doses ruined due to human error
About 15 million doses of Johnson & Johnson's one-shot vaccine have been ruined after a plant in the United States mixed up ingredients, The New York Times has reported.
28 Feb 2021
US FDA grants emergency use authorization for J&J's COVID-19 vaccine
The United States government on Saturday granted emergency approval to the COVID-19 vaccine developed by Johnson & Johnson, making it the third vaccine available to the public in the US.
25 Feb 2021
Johnson & Johnson's one-shot COVID-19 vaccine highly effective: FDA
Johnson & Johnson's single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released by US regulators that sets the stage for a final decision on a new and easier-to-use shot.
10 Feb 2021
Biological E aiming for 600 million J&J vaccine doses annually
Hyderabad-based pharmaceutical firm Biological E Ltd. is reportedly looking to contract-manufacture 600 million annual doses of the COVID-19 vaccine developed by Johnson & Johnson.
10 Feb 2021
South Africa scraps AstraZeneca vaccine, will give J&J jabs
South Africa will give the unapproved Johnson & Johnson vaccine to its frontline healthcare workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant in South Africa, Health Minister Zweli Mkhize announced on Wednesday.
29 Jan 2021
Johnson & Johnson's one-shot COVID-19 vaccine shows 66% strong efficacy
Johnson & Johnson's (J&J) much-awaited COVID-19 vaccine has reportedly exhibited strong protection against the virus.
22 Nov 2020
Bharat Biotech vaccine trials continued despite 'adverse event' in August
Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN.
16 Nov 2020
Moderna's COVID-19 vaccine found to be 95% effective: Details here
American biotech company Moderna Therapeutics has announced that its COVID-19 vaccine was found to be nearly 95% effective in preventing the novel coronavirus disease.
22 Oct 2020
AstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue
A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.
13 Oct 2020
Big setback: Johnson & Johnson pauses coronavirus vaccine trial
Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.
28 Sep 2020
NewsBytes Briefing: TikTok granted injunction against US ban, and more
Over the weekend, TikTok won a preliminary injunction against the Trump administration, which prevents the hit video service from getting banned in the US.
26 Sep 2020
Johnson & Johnson's single-dose COVID-19 vaccine induces strong immunity
Johnson & Johnson's COVID-19 vaccine has shown promise in early-to-mid-stage clinical human trials.
24 Sep 2020
NewsBytes Briefing: TikTok files for injunction against ban, and more
As ByteDance's TikTok deal is likely to see more delays owing to China's pending approval, the video company is moving to prevent itself from getting banned by Trump administration.
23 Sep 2020
Johnson & Johnson's COVID-19 vaccine goes into final human trials
In a major development, American pharma giant Johnson & Johnson has launched the final trial of its COVID-19 vaccine.
06 Sep 2020
COVID-19 vaccine developers to pledge against rolling out shots prematurely
In light of the havoc wreaked by COVID-19, governments around the world have become more than willing to fast-track regulatory approvals and launch promising vaccines, anti-virals, and tests for their citizens.
14 Aug 2020
NewsBytes Briefing: Fortnite removed from app stores, and more
In the updates since last night, Fortnite made major headlines.
06 Aug 2020
NewsBytes Briefing: Facebook, Twitter remove Trump's misleading post, and more
In the updates since last night, both Facebook and Twitter launched a crackdown on a misleading post from US President Donald Trump.
22 Jul 2020
As coronavirus pandemic surges, some vaccine makers expect to profit
Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.
22 Jul 2020
NewsBytes Briefing: Snap's revenue grows; Moderna's vaccine won't be cheap
The big story in the technology world is: Snap reported its earnings for Q2 2020 with notable gains - 9 million new users and 17% YoY growth in revenue.
05 Jul 2020
COVID-19 vaccine: What are the latest updates?
With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.
25 Jun 2020
Skin cream "Fair & Lovely" to drop "Fair" from name
Joining the bandwagon of brands that are making their products socially inclusive, the Indian unit of Unilever, Hindustan Unilever, has decided to drop "Fair" from the name of the skincare cream "Fair & Lovely," multiple reports said on Thursday.
11 Jun 2020
J&J to begin human trials of COVID-19 vaccine in July
American pharma giant Johnson & Johnson has announced that it will be starting human trials of its experimental COVID-19 vaccine sooner than previously planned.
19 Apr 2020
COVID-19 vaccine not guaranteed, says leading world health expert
With more than 160,000 deaths and 2.3 million infected cases globally, COVID-19 continues to wreak havoc around the world.
31 Mar 2020
Johnson & Johnson: COVID-19's vaccine will be ready by 2021
American pharmaceutical giant Johnson & Johnson has announced that it has selected the lead vaccine candidate for the novel coronavirus disease COVID-19.